Listen to Edward James Olmos describe why SENS is invaluable to defeating aging.
The longest running project at the SRF Research Center, the MitoSENS team has made ground-breaking discoveries in allotopic expression.
Dr. Tesfahun Admasu was selected as the first recipient of the Forever Healthy Foundation Fellowship in Rejuvenation Biotechnology, which began in summer 2019.
Since our founding in 2009, the establishment and ongoing expansion of our extramural research program has been a major part of SENS Research Foundation’s commitment to changing the way the world researches and treats age-related disease. We recognize that building and sustaining collaborations throughout a global research community is crucial to the realization of our mission. Toward this end, we fund work at some of the top universities and research institutions in the world. Learn more about each active project and how it relates to SRF’s mission using the links in this section.
Principal Investigator: Judith Campisi, PhD
Research Team: Abhijit Kale
Project Director: Julie Andersen, PhD
Research Team: Cyrene Arputhasamy, Manish Chamoli, Anand Rane
Project Director: Ruby Yanru Chen-Tsai, PhD
Principal Investigator: Jean Hébert, PhD
Research Team: Hiroko Nobuta, Joanna Krzyspiak, Alexandra Quezada, Marta Gronska-Peski, Jayleecia Smith
Principal Investigator: Tilman Grune, PhD
Research Team: Annett Braune, Annika Höhn, Tim Baldesperger
Principal Investigator: Jonathan Clark, PhD
Research Team: Melanie Stammers
Principal Investigator: Andrei Gudkov, PhD, DSci
Research Team: Marina Antoch, Amy Stablewski, Nick Neznanov, Lilya Novototskaya, Olga Leontieva
This research program has successfully spun-out into a company! Visit the Revel Pharmaceuticals website for more information on their transformative approach to tissue cross-linking and vascular disease.
Sign up to stay informed about the latest news and opportunities with SRF!
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2021 SENS Research Foundation – ALL RIGHTS RESERVED
